EphA4在乳腺癌组织中的表达及临床意义(2)
第1页 |
参见附件。
参考文献:
[1]De Mejia EG,Dia VP.The role of nutraceutical proteins and peptides in apoptosis,angiogenesis,and metastasis of cancer cells[J].Cancer Metastasis Rev,2010,29(3):511-528.
[2]郑庆峰,柳硕岩,王海燕,等.EphB4及其配体EphrinB2在食管鳞癌中的表达及其与血管生成的关系[J].中国肿瘤临床,2013,40(10):579-582.
[3]Tandon M,Vemula SV,Mittal SK.Emerging strategies for EphA2 receptor targeting for cancer therapeutics[J].Expert Opin Ther Targets,2011,15(1):31-51.
[4]Giorgio C,Hassan Mohamed I,Flammini L,et al.Lithocholic acid is an Eph-ephrin ligand interfering with Eph-kinase activation[J].PloS One,2011,6(3):e18128.
[5]Liizumi M,Hosokawa M,Takehara A,et al.EphA4 receptor,overexpressed in pancreatic ductal adenocarcinoma,promotes cancer cell growth[J].Cancer Sci,2006,97(11):1211-1216.
[6]Duxbury MS,Ito H,Zinner MJ,et al.EphA2:a determinant of malignant cellular behavior and a protential therapeutic target in pancreatic adenocarcinoma[J].Oncogene,2004,23(7):1448-1456.
[7]Oki M,Yamamoto H,Taniguchi H,et al.Overexpression of the receptor tyrosine kinase Epha4 in human gastric cancer[J].World J Gastroenterol,2008,14(37):5650-5656.
[8]王庆元,张谢夫,赵春临,等.EphA4在胃癌组织中的表达及意义[J].山东医药,2010,50(7):26-28.
[9]苏玲,张标,曹晓蕾.EphA4基因在胃癌中的表达及其与临床指标的关系[J].交通医学,2009,23(5):468-470.编辑/张燕
您现在查看是摘要介绍页,详见PDF附件。